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Abstract
Background: Case-control studies and outbreak investigations are the major epidemiological
tools for providing detailed information on enteric disease sources and risk factors, but these
investigations can be constrained by cost and logistics.
Methods: We explored the advantages and disadvantages of comparing risk factors for enteric
diseases using the case-case method. The main issues are illustrated with an analysis of routine
notification data on enteric diseases for 2006 collected by New Zealand's national surveillance
system.
Results: Our analyses of aggregated New Zealand surveillance data found that the associations
(crude odds ratios) for risk factors of enteric disease were fairly consistent with findings from local
case-control studies and outbreak investigations, adding support for the use of the case-case
analytical approach. Despite various inherent limitations, such an approach has the potential to
contribute to the monitoring of risk factor trends for enteric diseases. Nevertheless, using the
case-case method for analysis of routine surveillance data may need to be accompanied by: (i)
reduction of potential selection and information biases by improving the quality of the surveillance
data; and (ii) reduction of confounding by conducting more sophisticated analyses based on
individual-level data.
Conclusion: Case-case analyses of enteric diseases using routine surveillance data might be a
useful low-cost means to study trends in enteric disease sources and inform control measures. If
used, it should probably supplement rather than replace outbreak investigations and case-control
studies. Furthermore, it could be enhanced by utilising high quality individual-level data provided by
nationally-representative sentinel sites for enteric disease surveillance.
Background
In most developed countries, information on enteric dis-
ease epidemiology comes from a range of routine sources,
outbreak investigations and case-control studies con-
ducted outside of the context of an outbreak. The most
accessible information comes from routine compilations
of pathogen-specific surveillance data. This source usually
provides important information on demographic, tempo-
ral and geographic trends and can be used both to identify
potential outbreaks and to monitor trends that may sug-
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gest potential exposure sources. Maintaining and analys-
ing these data are a routine part of infectious disease
surveillance. Outbreak investigations are a necessary
extension of public health surveillance and are particu-
larly critical where the source of an outbreak is not well
established. However, risk factors and sources of disease
identified in the context of an outbreak may not always
reflect the major transmission pathways for the disease
agent in the general population. Case-control studies aim-
ing to investigate risk factors and sources of disease out-
side of outbreaks may be the best way to characterise
transmission pathways for the disease within populations
and for sporadic (non-outbreak) cases. However, such
studies are expensive, and go beyond the capacity of many
public health agencies.
For example, in the country we are most familiar with
(New Zealand), case-control studies have proved useful in
identifying risk factors for sporadic enteric infections
including campylobacteriosis [1-5], giardiasis [6-9], sal-
monellosis [10,11], and yersiniosis [12]. However, these
case-control studies have been demanding on limited
health worker time and public health resources. In these
studies recall bias has also been a serious concern and this
may be an increasing problem due to greater media pub-
licity around risk factors for common enteric diseases.
A potentially less expensive analytic approach, that may
be less susceptible to recall bias, is the case-case method.
This is a variant of the case-control design that was first
described in the 1980s when applied to cancer epidemiol-
ogy [13]. In infectious disease epidemiology, the case-case
method has usually involved comparisons between cases
infected with a different strain (or strains) of the same
infectious disease agent and selected from a similar sur-
veillance system [14]. It has been described as a useful
tool for communicable disease epidemiology [14] and
has been utilised for studying enteric disease outbreaks
(eg, salmonellosis [15] and campylobacteriosis [16,17])
and health outcomes from infection with enteric diseases
[18]. Here we consider the potential advantages and dis-
advantages of using the case-case method to identify risk
factors for enteric diseases using nationally collected rou-
tine surveillance data.
Methods
We explored the advantages and disadvantages of the
case-case method for studying risk factors for enteric dis-
eases using routine surveillance data, through compari-
sons with other studies (mainly case-control studies).
Domains that were considered on the basis of our under-
standing of the enteric disease epidemiological literature
were: (i) selection bias among cases; (ii) selection bias
among controls (or comparison cases in this instance);
(iii) information and recall bias; (iv) confounding; and
(v) lack of detail of exposures.
A worked example of case-case analyses for risk factor
comparisons used the routine national notification data
on enteric diseases for New Zealand in 2006. These data
are collected by the public health services of District
Health Boards and published by the Institute of Environ-
mental Science and Research Ltd (ESR), a national disease
surveillance and reference laboratory organisation [19].
Comparisons using aggregated national level data were
made to assess the associations between nine potential
risk factors for which data are routinely collected and six
different enteric diseases. Individual level analyses were
not possible as we did not have access to the individual
level data. Campylobacteriosis was used as the "reference
group" (comparison case group) for each case-case analy-
sis since this disease is relatively well studied in New Zea-
land, has fairly well-established risk factors [2,3,20] and is
the most frequently notified disease (so adequate num-
bers were available for all the analyses) [21]. Crude odds
ratios (OR) and 95% confidence intervals were calculated
using OpenEpi [22].
Notification data in New Zealand come from medical
practitioners who are legally required to report "notifiable
diseases" to their local Medical Officer of Health. Some
laboratories have also provided this information to health
authorities on a voluntary basis (though notification also
became a legal requirement for all laboratories in Decem-
ber 2007 under the Health Amendment Act 2006). Stand-
ardised forms used for enteric disease notifications
include risk factor questions and these are usually com-
pleted by public health staff interviewing cases over the
telephone. However, due to resource constraints, this risk
factor collection is far from complete (see Table 1).
Results
Specific results from the worked example
The results for the nine risk factors for which data are rou-
tinely collected are detailed in Table 1. Given the likely
methodological limitations of the data and this analysis
(see below) we only present these specific results for illus-
trative purposes and they should not be used on their own
for any decision-making by disease control agencies.
Significantly elevated crude odds ratios were apparent for
overseas travel and shigellosis (OR = 24), giardiasis (OR =
5.6) and salmonellosis (OR = 3.7). Elevated crude OR
were also evident for consumption of untreated drinking
water for giardiasis (OR = 2.9), cryptosporidiosis (OR =
2.7) and salmonellosis (OR = 1.3). For the latter three dis-
eases, this pattern was also evident for contact with recre-
ational water (as it was for shigellosis as well).Epidemiologic Perspectives & Innovations 2008, 5:6 http://www.epi-perspectives.com/content/5/1/6
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Table 1: Reported risk factor exposure and crude odds ratios for different notifiable enteric diseases (using published aggregate 
national data for 2006 [19])
Reported exposure to risk factor (RF)* Crude odds ratio (OR)**
Yes No Unknown % Reported the RF % Unknown OR 95% CI
Overseas travel
Shigellosis 49 32 21 60.5 20.6 23.9 15.1 – 37.8
Giardiasis 157 434 623 26.6 51.3 5.6 4.5 – 7.0
Salmonellosis 184 770 381 19.3 28.5 3.7 3.1 – 4.5
Cryptosporidiosis 43 480 213 8.2 28.9 1.4 1.0 – 1.9
Yersiniosis 19 266 202 6.7 41.5 1.1 0.69 – 1.8
Campylobacteriosis 304 4734 10,835 6.0 68.3 1.0 (ref)
Food consumption from a food premise
Shigellosis 23 24 55 48.9 53.9 0.87 0.49 – 1.5
Salmonellosis 310 364 661 46.0 49.5 0.77 0.66 – 0.91
Yersiniosis 72 136 279 34.6 57.3 0.48 0.36 – 0.64
Giardiasis 100 270 844 27.0 69.5 0.34 0.27 – 0.43
Cryptosporidiosis 79 225 432 26.0 58.7 0.32 0.24 – 0.42
Campylobacteriosis 2096 1903 11,874 52.4 74.8 1.0 (ref)
Consumption of untreated drinking water
Giardiasis 168 293 753 36.4 62.0 2.9 2.4 – 3.6
Cryptosporidiosis 152 286 298 34.7 40.5 2.7 2.2 – 3.3
Salmonellosis 149 588 598 20.2 44.8 1.3 1.1 – 1.6
Yersiniosis 47 187 253 20.1 52.0 1.3 0.92 – 1.8
Shigellosis 6 39 57 13.3 55.9 0.78 0.33 – 1.9
Campylobacteriosis 679 3451 11,743 16.4 74.0 1.0 (ref)
Contact with recreational water
Cryptosporidiosis 143 337 256 29.8 34.8 3.5 2.8 – 4.4
Giardiasis 138 359 717 27.8 59.1 3.2 2.6 – 4.0
Shigellosis 10 35 57 22.2 55.9 2.4 1.2 – 4.8
Salmonellosis 134 667 534 16.7 40.0 1.7 1.4 – 2.1
Yersiniosis 29 222 236 11.6 48.5 1.1 0.73 – 1.6
Campylobacteriosis 474 3948 11,451 10.7 72.1 1.0 (ref)
Contact with farm animals
Cryptosporidiosis 284 250 202 53.2 27.4 2.8 2.4 – 3.4
Yersiniosis 72 136 279 34.6 57.3 1.3 0.99 – 1.8
Giardiasis 139 365 710 27.6 58.5 0.95 0.77 – 1.2
Salmonellosis 217 643 475 25.2 35.6 0.84 0.71 – 0.99
Shigellosis 2 43 57 4.4 55.9 0.12 0.03 – 0.48
Campylobacteriosis 1289 3215 11,369 28.6 71.6 1.0 (ref)
Contact with sick animals
Cryptosporidiosis 107 333 296 24.3 40.2 7.1 5.4 – 9.2
Giardiasis 24 412 778 5.5 64.1 1.3 0.82 – 2.0
Salmonellosis 37 747 551 4.7 41.3 1.1 0.76 – 1.6
Yersiniosis 11 230 246 4.6 50.5 1.0 0.56 – 2.0
Shigellosis 0 45 57 0.0 55.9 0.0 -
Campylobacteriosis 177 3884 11,812 4.4 74.4 1.0 (ref)
Contact with symptomatic people
Giardiasis 146 327 741 30.9 61.0 3.9 3.2 – 4.9
Cryptosporidiosis 118 365 253 24.4 34.4 2.9 2.3 – 3.6
Shigellosis 11 46 45 19.3 44.1 2.1 1.1 – 4.1
Salmonellosis 107 705 523 13.2 39.2 1.3 1.1 – 1.7
Yersiniosis 24 222 241 9.8 49.5 0.95 0.61 – 1.5
Campylobacteriosis 442 3901 11,530 10.2 72.6 1.0 (ref)Epidemiologic Perspectives & Innovations 2008, 5:6 http://www.epi-perspectives.com/content/5/1/6
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Contact with farm animals and contact with sick animals
were apparent risk factors for cryptosporidiosis (OR = 2.8
and OR = 7.1 respectively). For contact with symptomatic
people all diseases except yersiniosis had elevated OR.
This pattern also held for contact with confirmed cases
(except it was no longer significant for salmonellosis).
Contact with human faecal matter had elevated OR for all
diseases except salmonellosis and shigellosis.
There were some diseases where the OR were significantly
lower than for the reference disease of campylobacteriosis.
That pattern was seen for all the diseases, except shigello-
sis, for consumption of food from a food premise; and for
both salmonellosis and shigellosis for contact with farm
animals. These findings may suggest that these risk factors
are significantly more important for campylobacteriosis
than for these other diseases in the New Zealand context.
Limitations of case-case analyses using surveillance data
Our comparative analyses of enteric disease risk factors
using the case-case method and routine surveillance data
identified some important limitations with this approach.
These limitations are illustrated with examples drawn
from New Zealand's infectious diseases surveillance sys-
tems:
1) Selection bias among cases
A possible selection bias is that risk factor exposures
among the study cases may be atypical because the cases
are not representative of all cases in the population
(indeed probably only a small proportion of all cases
[23]). For example, the cases may tend to be more severe
with more serious symptoms that increase the likelihood
of them seeking medical attention. In New Zealand few
enteric disease cases are likely to be notified on suspicion
to the local health authorities (the District Health Boards
in NZ), and most will therefore be laboratory-confirmed.
For laboratory-confirmed cases of enteric disease, there
are likely to be large selection biases associated with the
type of people who seek medical advice when they have
gastrointestinal symptoms, from whom a stool specimen
is requested by a doctor and then who actually provide a
stool specimen to a laboratory to confirm the cause [23-
25]. Furthermore, under the current 'passive' system of
disease notification in New Zealand, one study reported
that 23% of laboratory-confirmed cases of enteric disease
were not notified (range: 12% for shigellosis 24% for
campylobacteriosis [26]), so further unknown selection
biases may operate for laboratory-confirmed cases which
are notified. However, with recent legislation requiring
mandatory laboratory notification nation-wide, this situ-
ation should improve.
Similar selection bias may also occur in case-control stud-
ies which use notified or laboratory-confirmed cases.
Arguably, there is greater potential for selection bias with
case-control studies where cases are derived from notifica-
tions but where controls are recruited from a difference
source (commonly from the general population via tele-
phone in New Zealand).
2) Selection bias among controls or comparison cases
A specific limitation of case-case analysis is that the esti-
mated strength of the exposure-disease association is
strongly influenced by the level of exposure reported by
the comparison cases. If the exposure was a protective fac-
tor for the comparison cases (those with the reference dis-
ease), then this analysis would tend to over-estimate the
strength of association. By contrast, if the exposure is also
a risk factor for the reference disease, then this type of
case-case analysis will under-estimate the strength of the
association. Changes in the pattern of exposure among
Contact with confirmed cases (of the same specific disease)
Giardiasis 108 414 692 20.7 57.0 7.3 5.7 – 9.5
Shigellosis 8 49 45 14.0 44.1 4.6 2.1 – 9.8
Cryptosporidiosis 27 417 292 6.1 39.7 1.8 1.2 – 2.8
Salmonellosis 35 739 561 4.5 42.0 1.3 0.92 – 1.9
Yersiniosis 1 201 285 0.5 58.5 0.14 0.02 – 1.0
Campylobacteriosis 185 5210 10,478 3.4 66.0 1.0 (ref)
Contact with human faecal matter
Giardiasis 151 324 739 31.8 60.9 3.6 2.9 – 4.4
Cryptosporidiosis 151 343 242 30.6 32.9 3.4 2.7 – 4.2
Yersiniosis 49 202 236 19.5 48.5 1.9 1.3 – 2.6
Salmonellosis 117 701 517 14.3 38.7 1.3 1.0 – 1.6
Shigellosis 3 49 50 5.8 49.0 0.47 0.15 – 1.5
Campylobacteriosis 504 3850 11,519 11.6 72.6 1.0 (ref)
Notes:
* For within the incubation period of each particular disease.
** Crude odds ratios not adjusted for sex, age, ethnicity or any other covariates.
Table 1: Reported risk factor exposure and crude odds ratios for different notifiable enteric diseases (using published aggregate 
national data for 2006 [19]) (Continued)Epidemiologic Perspectives & Innovations 2008, 5:6 http://www.epi-perspectives.com/content/5/1/6
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the comparison cases could result in spurious changes to
the estimated exposure-disease association, and this pos-
sible explanation should be considered where associa-
tions change over time. However, given that the exposures
reported for these diseases are all well-established risk fac-
tors for most enteric diseases, results from this risk factor
comparative analysis will tend to be conservative (ie,
biased towards not showing an association). Examples of
this are the results for "overseas travel" and for "food con-
sumption from a food premise" (Table 1) where these risk
factors are already known for campylobacteriosis in the
New Zealand setting [2,20].
3) Information/recall biases
Information biases may occur in a case-case analysis due
to biased investigator data collection or respondent recall
of exposure. The systems for collecting risk factor informa-
tion from cases of notifiable enteric diseases are often het-
erogeneous, particularly in countries where health
systems vary at district or regional levels. For example, in
New Zealand information collection can involve inter-
views by communicable disease clerks, health protection
officers or even self-completion of printed questionnaires
by cases. Both case investigators and cases are usually
aware of the specific enteric disease diagnosis when risk
factor data are being collected. Information bias may
therefore occur as some of these risk factors may be well
known by case investigators and cases themselves (eg,
campylobacteriosis and food; giardiasis and untreated
water). This situation could result in improved or even
false recall of exposure to specific well-known risk factors
or to exposures which are widely viewed as risk factors for
enteric infections, increasing the observed association
with the disease. However, as for case-case studies, case-
control studies are also likely to be affected by such recall
biases. Indeed, recall bias is likely to be a larger problem
for case-control analyses involving community controls,
as such controls will not have had a gastro-intestinal infec-
tion to stimulate recall of known or suspected causes of
these diseases.
4) Confounding
There are numerous potential confounders in any case-
case analysis using aggregated routinely collected enteric
disease surveillance data (eg, age, gender, socioeconomic
status, ethnicity, rurality, month of infection and variable
length of incubation period for the different diseases).
These effects may be reduced through using comparison
cases with other laboratory-confirmed enteric infections,
though this is certainly not guaranteed. Appropriate
adjustment for these potential confounders using individ-
ual data may well be worthwhile once improvements in
surveillance data quality are made (eg, the proportion of
"unknown" responses to each exposure in Table 1 is
reduced). Indeed, in many jurisdictions it is possible that
the address data of cases could be used to obtain a meas-
ure of socioeconomic position for each case (eg, in New
Zealand using "NZDep", a small area measure of social
deprivation [27]).
5) Lack of detail of exposures
The scope of specific exposures recorded in routine sur-
veillance data is always going to be restricted and in the
New Zealand example it was limited to just nine. Further-
more, some of these risk factors were quite broad in
nature (eg, Food consumption from a food premise). Conse-
quently, the findings do not provide a particularly strong
basis for taking specific public health action to reduce
exposures to these sources. This limitation could be
reduced by improved data collection with greater detail,
specificity and completeness of the exposure data. This
expansion could extend to a "shotgun" type questionnaire
to provide a tool for rapid hypothesis generation for use
in outbreak situations (eg, as used by the Oregon State
Department of Human Services: http://www.oregon.gov/
DHS/ph/acd/keene.shtml). The obvious trade-off would
be the additional time and resources required to obtain
detailed exposure history information. As noted later in
the Discussion Section, this extension could be facilitated
through the use of sentinel data collection sites.
Strengths of case-case analyses using surveillance data
As described above, many of the limitations of case-case
analyses for enteric diseases are common to case-control
studies. Both share the limitations with what participants
can observe and report, the long exposure windows for
some pathogens, and the uncertain effects of population
immunity for some of these enteric diseases [28,29].
However, the recall bias problem is probably greater with
case-control studies so that is a relative strength of the
case-case approach.
Another strength of the case-case approach over the case-
control one is that by using routinely collected data it is
potentially much less expensive. This cost barrier may
partly explain why case-control studies are done infre-
quently. For example, in New Zealand there has never
been a reported case-control study investigating sporadic
(non-outbreak) cryptosporidiosis and shigellosis. Also, by
being easier to undertake, these case-case analyses may be
more readily made a routine part of ongoing national sur-
veillance activities. Indeed, community controls for case-
control studies are becoming very difficult and expensive
to obtain due to the low participation rate from telephone
recruitment methods (eg, only 21.4% in a recent New
Zealand study [30]).
A further relative advantage of the case-case approach
could be timeliness as the analyses can use already col-
lected case data. This requirement is particularly impor-Epidemiologic Perspectives & Innovations 2008, 5:6 http://www.epi-perspectives.com/content/5/1/6
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tant in some rapidly evolving outbreaks, such as may
occur where a widely distributed food is contaminated
with a serious disease causing agent such as verotoxigenic
E. coli [31]. Control of such outbreaks depends on swiftly
generating and investigating hypotheses about the source
of the infection. So rather than expending weeks collect-
ing data from controls, the historical case data from the
surveillance system could be analysed quickly (with the
new case data) for an initial case-case investigation to see
if any of the major risk factors are involved.
Discussion
Interpretation of the example results
For the worked example using New Zealand surveillance
data it is apparent that the associations are fairly consist-
ent with other published New Zealand evidence about
risk factors for specific enteric diseases eg:
• Overseas travel and shigellosis based on an outbreak
investigation [32] and also giardiasis based on two case-
control studies [7,9].
￿ Drinking water and giardiasis based on case-control
studies [6-9] and also plausible for cryptosporidiosis
given the results of a cross-sectional survey [33].
￿ Contact with farm animals and cryptosporidiosis based
on an outbreak investigation [34]. Of note however, is the
possibility that outbreaks sometimes reflect atypical expo-
sure pathways and so can produce different findings from
analytic epidemiological studies involving sporadic cases.
￿ Contact with confirmed cases and giardiasis has not
been specifically assessed in previous New Zealand stud-
ies but the risk associated with human waste exposure is
well documented for this country based on case-control
studies [7,9,35] which suggests that some forms of
human-to-human transmission may be important in this
setting.
The finding that there were some diseases with an OR that
was statistically significantly lower than for the reference
disease of campylobacteriosis was also not surprising.
That is because there is good evidence from many studies
that contaminated food (especially fresh poultry) is an
important risk factor for campylobacteriosis in New Zea-
land [20,36].
The findings therefore suggest that case-case analysis using
routine data may provide supplementary information on
risk factors for enteric diseases. Repeated over time, this
approach could potentially provide further information
on progress with disease prevention interventions (eg, as
rural water supply quality in New Zealand continues to
improve, the associated elevated risks for consuming
untreated water should decline over time). But interpret-
ing apparent trends for an enteric disease would need a lot
of additional contextual information, including changes
in exposure experienced by the comparison cases with the
reference disease(s).
It is also conceivable that these case-case analyses could
identify newly emerging risk factors if repeated periodi-
cally (six-monthly or annually) and act as a trigger for
more in-depth investigations. Nevertheless, we would
argue against any of these routine uses of such case-case
analyses with current New Zealand data until further work
is done to assess the importance of the biases detailed in
the Results Section.
Implications for improving surveillance data
Given the considerations detailed in the preceding Results
Section, we recommend that countries wishing to under-
take supplementary case-case analyses with routine
enteric disease surveillance data ensure that they have
high quality data collection processes. For New Zealand,
this would mean reducing the large proportions of
"unknowns" as listed in Table 1 and improving the avail-
ability of data on potential confounding factors. The most
efficient way to do this may be to establish a number of
appropriately resourced specialised sentinel surveillance
sites that collect more comprehensive and complete infor-
mation.
Sentinel surveillance is "surveillance based on selected
population samples chosen to represent the relevant expe-
riences of particular groups" [37]. This approach is used
where the health event is very common and it would be
impractical to record every case, or where more intense
effort is used to collect additional data on a sub-sample of
cases. In New Zealand, sentinel surveillance is well estab-
lished for monitoring seasonal influenza where general
practitioners provide data on patients consulting them for
influenza-like illness [38]. General practice sentinel sur-
veillance has also been successfully used on a trial basis to
collect data on acute gastroenteritis presenting to general
practitioners in New Zealand [39]. Elsewhere, ongoing
sentinel surveillance of gastroenteritis does not appear to
be widely used. One of the few reported examples is the
French sentinel surveillance system which includes acute
diarrhoea as one of the conditions under surveillance
[40].
We are not aware of New Zealand examples of sentinel
surveillance where additional exposure or risk factor
information is collected on a sample of cases on an ongo-
ing basis. However, there are several diseases where con-
siderable risk factor/exposure data are collected on all
cases, with HIV/AIDS being probably the best example
[41]. Similarly, we are not aware of international exam-Epidemiologic Perspectives & Innovations 2008, 5:6 http://www.epi-perspectives.com/content/5/1/6
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ples of ongoing sentinel surveillance of gastroenteritis that
collects risk factor or exposure information beyond basic
demographic and possibly travel history information.
More intensive surveillance of this type has, however,
been successfully used as part of specific research studies
on intestinal infectious diseases in the United Kingdom
[23,24] and The Netherlands [25].
Developing sentinel surveillance system for gastrointesti-
nal illness could reduce most of the limitations of case-
case analyses described above (the one exception being
selection bias among comparison cases). Sentinel surveil-
lance could reduce selection bias among cases by putting
greater effort into obtaining faecal specimens from
patients presenting with gastroenteritis. Information/
recall biases could be reduced by shortening the time
delay before interviewing cases (potentially interviewing
cases while waiting for laboratory test results). Confound-
ing could be reduced by collecting more complete data
from cases allowing for adjusted analyses of individual
level data. Lack of detail of exposures could be reduced
through the use of highly detailed questionnaires covering
important disease sources (the "shotgun" type question-
naires referred to above).
Some of the extra cost of running these sites could be off-
set by a reduced need for collecting routine risk factor data
in the non-sentinel areas (eg, on more common enteric
diseases such campylobacteriosis). If sentinel sites were
appropriately resourced then they could also run case-
control studies, case-case studies (between strains) and
case-crossover studies that would allow direct compari-
sons with the cruder case-case method used here. For case-
control studies the controls could possibly be selected
from the general practices involved in notifying the cases
(given the difficulty in recruiting community controls in
many developed countries). This approach could provide
an established population of controls to facilitation rapid
outbreak investigation ie a "control bank" [42,43].
Conclusion
Despite various inherent limitations, case-case analyses
using routine surveillance data have the potential to sup-
plement other studies to assist in monitoring risk factor
trends for enteric diseases. They may also help with mon-
itoring the impact of interventions and could potentially
provide a base for rapid outbreak investigations. Never-
theless, adopting this approach may need to be accompa-
nied by moves to: (i) reduce potential selection and
information biases by improving the quality of the sur-
veillance data; and (ii) reduce confounding by undertak-
ing more sophisticated analyses of individual data. These
improvements could be facilitated by establishing high
quality sentinel sites for enteric disease surveillance. For
the particular New Zealand data studied, it was apparent
that the case-case analyses of enteric diseases data pro-
duced information that was consistent with findings from
local case-control studies and outbreak investigations.
That observation adds support for the use of this type of
case-case analysis for investigating sources and studying
the impact of control measures for enteric diseases.
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